MUC16, also known as CA125, is a type I transmembrane glycosylated protein, which is involved in the growth, proliferation, apoptosis inhibition, chemotherapy resistance, metabolic reprogramming, and immune evasion of tumour cells [71, 72]. This evidence concerns the gene MUC16 and neoplasm.